Renxiang Chen, Ph.D. - Publications
Affiliations: | 2004 | Ohio State University, Columbus, Columbus, OH |
Area:
Molecular Biology, PharmacologyYear | Citation | Score | |||
---|---|---|---|---|---|
2005 | Chen R, Yokoyama M, Sato H, Reilly C, Mansky LM. Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies. Journal of Virology. 79: 12045-57. PMID 16140780 DOI: 10.1128/Jvi.79.18.12045-12057.2005 | 0.348 | |||
2005 | Chen R, Quinones-Mateu ME, Mansky LM. HIV-1 mutagenesis during antiretroviral therapy: implications for successful drug treatment. Frontiers in Bioscience : a Journal and Virtual Library. 10: 743-50. PMID 15569614 DOI: 10.2741/1568 | 0.336 | |||
2004 | Chen R, Quinones-Mateu ME, Mansky LM. Drug resistance, virus fitness and HIV-1 mutagenesis. Current Pharmaceutical Design. 10: 4065-70. PMID 15579088 DOI: 10.2174/1381612043382404 | 0.335 | |||
2004 | Chen R, Le Rouzic E, Kearney JA, Mansky LM, Benichou S. Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages. The Journal of Biological Chemistry. 279: 28419-25. PMID 15096517 DOI: 10.1074/Jbc.M403875200 | 0.301 | |||
2003 | Jewell NA, Chen R, Raices R, Mansky LM. Nucleoside reverse transcriptase inhibitors and HIV mutagenesis. The Journal of Antimicrobial Chemotherapy. 52: 547-50. PMID 12951341 DOI: 10.1093/Jac/Dkg387 | 0.313 | |||
Show low-probability matches. |